PRL and breast carcinoma: Prolactin in breast cancer cells could induce the phosphorylation of ERBB2/HER2, which in turn activates the downstream RAS/MEK/ERK pathway, leading to the proliferation of breast cancer (Kavarthapu et al., 2021).